$19.88 -0.11 (-0.55%) Akorn Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 19.88
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: -0.11 (-0.55%)
Prev Close: 19.99
Open: 19.92
Bid: 19.86
Ask: 19.87
  1. Magic Recipe Movers - The Trump Effect

    TalkMarkets | Nov. 13, 2016 | 22:45PM EST
  2. Stocks Remain Indecisive; Jack In The Box, Fitbit Score Big Gains

    Investors Business Daily | Aug. 4, 2016 | 14:29PM EST
  3. Stock Futures Up, Europe Rallies On BOE Vote; Monster On Deck

    Investors Business Daily | Aug. 4, 2016 | 07:58AM EST
  4. John Paulson Bulks Up Health Care Bet

    GuruFocus | Feb. 17, 2016 | 17:02PM EST
  5. Top-Notch Funds Buying Constellation, Northrop Grumman

    IBD | Jan. 8, 2016 | 17:56PM EST
  6. Piper Jaffray: Akorn's Stock Will Be Delisted In 2016

    Benzinga | Dec. 18, 2015 | 11:18AM EST
  7. Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016

    Benzinga | Dec. 18, 2015 | 10:52AM EST
  8. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio

    Benzinga | Oct. 27, 2015 | 03:23AM EST
  9. Biotechs, Medicals Whacked As Nasdaq Trades Near Day's Low

    IBD | Oct. 6, 2015 | 12:23PM EST
  10. Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon

    Benzinga | Sep. 17, 2015 | 06:00AM EST
  11. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 13:48PM EST
  12. Akorn's

    IBD | Aug. 4, 2015 | 17:41PM EST
  13. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 12:08PM EST
  14. 5 Mid-Caps With Unsustainable Cash Burn Rates

    Benzinga | Jul. 27, 2015 | 08:23AM EST
  15. Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral

    Benzinga | Jul. 21, 2015 | 10:31AM EST
Trading Center